$EDIT short under 70

11 בדצמ׳ 2020

EDIT up +140% over last 3 days. Pullback expected here. Gene editing is a hot topic at the moment, but price is absolutely overextended for company with less than 100M revenue annually. Long term huge long potential. Short term, short biased.

17 במרץ 2021

עסקה סגורה: היעד הושג